JaxPool by Jax.Network launches the initial configuration for its public API
DUBAI, United Arab Emirates, Oct. 14, 2022 (GLOBE NEWSWIRE) — Jax.Network, a blockchain project building…
News
LBank Exchange Listed Carbon Neutrality Blockchain (CNB) on October 12, 2022
Internet City, Dubai–(Newsfile Corp. – October 14, 2022) – LBank Exchange, a global digital asset…
InfoComm Southeast Asia Back In-person
BANGKOK, Oct 14, 2022 – (ACN Newswire) – InfoComm Southeast Asia which debuted in 2019…
Samaiden Group Signs Partnership Agreement with Taiwan-based Monitoring Solution Provider Thingnario
PETALING JAYA, Malaysia, Oct 14, 2022 – (ACN Newswire) – Samaiden Group Berhad (Bursa: SAMAIDEN,…
Avery Restaurant Consulting Awarded Top Hospitality Marketing Solutions Provider
Avery Restaurant Consulting recently entered Travel & Hospitality Tech Outlook’s 2022 list of Top 10…
FRMO Corp. Announces Fiscal 2023 First Quarter Results and Conference Call
WHITE PLAINS, N.Y.–(BUSINESS WIRE)–FRMO Corp. (the “Company” or “FRMO”) (OTC Pink: FRMO) today reported its…
Indonesia to offer 80/160-year building (HGB) permits in IKN Nusantara to incentivise investment
JAKARTA, Oct 14, 2022 – (ACN Newswire) – Indonesia’s Ministry of Agrarian Affairs and Spatial…
CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual Congress
BEIJING & BURLINGTON, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading global biopharmaceutical company, with a…
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the…
Enliven Therapeutics and Imara Announce Merger Agreement
Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Enliven’s portfolio of precision oncology…
Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
Company presenting technologies for improving patient outcomes in wound care WINNIPEG, Manitoba, Oct. 13, 2022…
Kymera Therapeutics to Hold Investor Webcast on December 14 to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline
Dosing in KT-474 Phase 1 HS and AD patient cohort (Part C) complete KT-413 and…
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (NASDAQ: SEER), a life…
ERYTECH Announces Receipt of Nasdaq Notice
ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022…
Travere Therapeutics Provides Regulatory Update on its Sparsentan Program for IgA Nephropathy
Conference call and webcast to be held at 4:30p.m. ET SAN DIEGO, Oct. 13, 2022…
Paratek Pharmaceuticals Presenting New Data for NUZYRA® (omadacycline) at IDWeek 2022
Highlights include data from non-clinical and microbiology programs and real-world patient use BOSTON, Oct. 13,…
IO Biotech Announces Appointment of New Chief Financial Officer
NEW YORK, Oct. 13, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery Platform
WALTHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) — Invivyd, (Nasdaq: IVVD) a clinical-stage biopharmaceutical company…
BridgeBio Pharma Presents Updated Positive Data from its BBP-812 Canavan Disease Gene Therapy Program at the 51st Annual Meeting of the Child Neurology Society
– Robust post-dosing changes continue to be seen in key markers associated with severity of…
Sanofi: Information concerning the total number of voting rights and shares – September 2022
Information concerning the total number of voting rights and shares, provided pursuant to article L….